Litigation Details for Shionogi Inc. v. Aurobindo Pharma Ltd. (D. Del. 2017)
✉ Email this page to a colleague
Shionogi Inc. v. Aurobindo Pharma Ltd. (D. Del. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-01-24 |
Court | District Court, D. Delaware | Date Terminated | 2020-11-17 |
Cause | 35:0145 | Assigned To | Mitchell S. Goldberg |
Jury Demand | None | Referred To | David R. Strawbridge |
Patents | 6,790,459; 6,866,866 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Shionogi Inc. v. Aurobindo Pharma Ltd.
Details for Shionogi Inc. v. Aurobindo Pharma Ltd. (D. Del. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-01-30 | 116 | on United States Patent No. 6,790,459 (the “‘459 Patent”) and United States Patent No. 6,866,866 (…the validity of a United States patent before the United States Patent and Trademark Office. …), for allegedly infringing two of Plaintiffs’ patents. Defendants have filed counterclaims, alleging…alleging the invalidity and non-infringement of these patents. Plaintiffs urge that all of these … I. FACTUAL BACKGROUND A. Patents at Issue On January 25, 2017, Shionogi | External link to document | |
2017-08-14 | 13 | a complaint for patent infringement of U.S. Patent Nos. 6,790,459 (“the ’459 Patent”) and 6,866,866 (… ’459 Patent and the ’866 Patent, and declaratory judgment of noninfringement of the ’459 Patent. (Id.…vii)(l\/) for U.S. Patent Nos. (“the ’459 Patent”) and 6,866,866 (“the ’866 Patent”). Aurobindo further…’459 Patent and the ’866 Patent, and declaratory judgment cf noninfringement of the ’459 Patent. (]d.… (“the ’866 Patent”) (collectively, the “Patents-m~Suit”) against Defendants and Counterclaim-Plaintiffs | External link to document | |
2017-01-24 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,790,459; 6,866,866. (nmg) (… 18 November 2020 1:17-cv-00072 830 Patent None District Court, D. Delaware | External link to document | |
2018-06-05 | 70 | Redacted Document | Plaintiffs”) for patent infringement of U.S. Patent Nos. 6,790,459 (“the ’459 Patent”) and 6,866,866…6,866,866 (“the ’866 Patent”) (collectively, the “Patents-in-Suit”) against Aurobindo Pharma Ltd. and Aurobindo…proceedings before the Patent Trial and Appeal Board. In the proceeding involving the ’866 patent, Plaintiffs …proceeding involving the ’459 patent, Plaintiffs are scheduled to file the Patent Owner’s Preliminary Response…and resources of the parties, this Court, and the Patent Office by continuing to litigate a dispute that | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |